These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16731612)

  • 1. Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change.
    Fitzpatrick F; McGaley T; Rajan L; Crowley R; Turley M; Humphreys H; Smyth E
    J Clin Pathol; 2006 Jun; 59(6):666-7. PubMed ID: 16731612
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of vancomycin should be monitored in burn patients.
    Dell'Aquila AM; McCulloch JA; Mamizuka EM; Santos SR; Pereira CA
    Burns; 2004 Jun; 30(4):386-7. PubMed ID: 15145199
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin peak serum concentration monitoring.
    Tam VH; Moore GE; Triller DM; Briceland LL
    J Intraven Nurs; 1999; 22(6):336-42. PubMed ID: 10865602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on vancomycin dosing and monitoring practices in hemodialysis patients.
    Zhang M; Dresser L; Battistella M
    CANNT J; 2013; 23(4):25-7; quiz 28-9. PubMed ID: 24660521
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glycopeptides (vancomycin, teicoplanin)].
    Furuta I; Kitahashi T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():423-6. PubMed ID: 15658354
    [No Abstract]   [Full Text] [Related]  

  • 6. Pitfalls in TDM of antibiotic drugs: analytical and modelling issues.
    Neef C; Touw DJ; Harteveld AR; Eerland JJ; Uges DR
    Ther Drug Monit; 2006 Oct; 28(5):686-9. PubMed ID: 17038886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glycopeptides (vancomycin, teicoplanin)].
    Furuta I; Kitahashi T
    Nihon Rinsho; 1999 Sep; 57 Suppl():401-3. PubMed ID: 10543138
    [No Abstract]   [Full Text] [Related]  

  • 8. Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
    Matsumoto K; Takesue Y; Ohmagari N; Mochizuki T; Mikamo H; Seki M; Takakura S; Tokimatsu I; Takahashi Y; Kasahara K; Okada K; Igarashi M; Kobayashi M; Hamada Y; Kimura M; Nishi Y; Tanigawara Y; Kimura T
    J Infect Chemother; 2013 Jun; 19(3):365-80. PubMed ID: 23673472
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behaviour of vancomycin with the new techniques in haemodialysis].
    Bravo JJ; Díaz A; Donado E; Tarragó J; Tato F; Romero R; Sánchez-Guisande D; Mardaras J
    Nefrologia; 2005; 25(5):527-34. PubMed ID: 16392303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin dosing and monitoring.
    Med Lett Drugs Ther; 2009 Apr; 51(1309):25. PubMed ID: 19343006
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of antibacterial agents in renal failure.
    Livornese LL; Slavin D; Gilbert B; Robbins P; Santoro J
    Infect Dis Clin North Am; 2004 Sep; 18(3):551-79, viii-ix. PubMed ID: 15308276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest in therapeutic drug monitoring of the main antibiotics].
    Davani S; Muret P; Royer B; Hoen B; Kantelip JP
    Ann Biol Clin (Paris); 2002; 60(6):655-61. PubMed ID: 12446229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trough-only monitoring of serum vancomycin concentrations in neonates.
    Shackley F; Roberts P; Heath P; Bowler I; Saunders NJ
    J Antimicrob Chemother; 1998 Jan; 41(1):141-2. PubMed ID: 9511053
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vancomycin dosing in hemodialysis patients].
    Castellano I; González Castillo PM; Covarsí A; Martínez Sánchez J; Suárez Santisteban MA; Gallego S; Marigliano N
    Nefrologia; 2008; 28(6):607-12. PubMed ID: 19016633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial drug therapy and microbial sensitivity tests--measurement of antibiotics concentration in body fluids].
    Kitahashi T
    Rinsho Byori; 1997 Jul; Suppl 105():196-202. PubMed ID: 9379540
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment.
    Wilson JF; Davis AC; Tobin CM
    J Antimicrob Chemother; 2003 Jul; 52(1):78-82. PubMed ID: 12805260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding vancomycin levels.
    Rosini JM; Srivastava N
    Nursing; 2013 Nov; 43(11):66-7. PubMed ID: 24141590
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks.
    Nakayama H; Echizen H; Tanaka M; Sato M; Orii T
    Ther Drug Monit; 2008 Feb; 30(1):103-7. PubMed ID: 18223471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin: the need to suit serum concentrations in hemodialysis patients.
    Marengo LL; Del Fiol Fde S; Oliveira Sde J; Nakagawa C; Croco EL; Barberato-Filho S; Peçanha MP; Silva DF; Toledo MI
    Braz J Infect Dis; 2010; 14(2):203-8. PubMed ID: 20563453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin levels: to draw or not to draw.
    Creekmore F
    S D J Med; 1998 Jun; 51(6):195-6. PubMed ID: 9646718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.